Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Outlines Priorities For Next Five Years In Strategic Report

This article was originally published in The Gray Sheet

Executive Summary

Improving FDA's scientific know-how and regulatory tools while strengthening enforcement activities will be top priorities for the agency over the next five years, according to a new strategic report

You may also be interested in...



Regulatory News In Brief

FDA five-year strategic priorities

Regulatory News In Brief

FDA five-year strategic priorities

Regulatory News In Brief

FDA's strategic priorities

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT029450

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel